| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5956286 | Chest | 2012 | 9 Pages |
Abstract
TTF-1 shows independent prognostic significance in advanced lung adenocarcinoma. Patients with TTF-1-negative lung adenocarcinoma have not only shorter OS, but also shorter PFS under EGFR TKI treatment, despite the existence of mutant EGFR. Further studies are needed to investigate the optimal treatment of patients with TTF-1-negative lung adenocarcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kuei-Pin MD, Yen-Tsung MD, MPH, Yih-Leong MD, PhD, Chong-Jen MD, PhD, Chih-Hsin MD, PhD, Yeun-Chung MD, Jin-Yuan MD, PhD, Pan-Chyr MD, PhD, FCCP,